一项国家随机对照试验的协议,评估阿片类药物快速反应系统,以预防过量死亡
Dametreea L Carr1, Michael L Hecht1, Michelle N Shiota2
1REAL Prevention LLC, 130 Pearl Brook Drive, Clifton, NJ 07013, USA.
Contemporary clinical trials
|February 5, 2025
概括
"阿片类药物快速反应系统" (ORRS) 培训普通公民注射纳洛,旨在减少阿片类药物过量死亡. 这项以理论为导向的课程重点是招聘和培训策略,以改善减少危害的结果.
科学领域:
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
- 应急响应应对紧急情况的反应.
背景情况:
- 过量服用阿片类药物导致的死亡是美国重大公共卫生危机.
- 纳洛的使用对于逆转过量服用至关重要,但需要及时干预.
- 目前的纳洛分销策略需要更有效,基于证据的招聘和培训方法.
研究的目的:
- 评估阿片类药物快速反应系统 (ORRS) 在招募和培训平民应对阿片类药物过量使用方面的有效性.
- 推进对有效的招聘和培训策略的科学理解,以促进基于社区的减少危害计划.
- 通过增强非专业人士的反应来降低与阿片类药物过量服用相关的死亡率.
主要方法:
- 一项随机对照试验 (RCT) 将评估宾夕法尼亚州,亚利桑那州和华盛顿州9个社区的ORRS有效性.
- 测试前和测试后的调查将测量培训成果.
- 焦点小组将为ORRS培训模块的开发提供信息,强调志愿者招募的个人和社会身份.
主要成果:
- 该研究旨在提供关于ORRS模型有效性的数据.
- 结果将表明理论驱动的招聘和培训对普通公民对阿片类药物过量反应的准备能力的影响.
- 训练有素的社区成员将评估纳洛的有效性.
结论:
- "阿片类药物快速反应系统"是一项新的,以理论为导向的计划,旨在赋予普通公民应对阿片类药物过量紧急情况的权力.
- 通过改善纳洛的可访问性和管理,ORRS有可能对减少危害的努力做出重大贡献.
- 该计划旨在减少阿片类药物过量使用导致的死亡人数,并增强社区的恢复力.
更多相关视频
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
5.2K
12:20Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
21.1K
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
211
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
211
Opioid Receptors: Overview
443
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
443
Analgesia and Pain Management
443
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
443
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
